Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nebozhyn

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Science (New York, N.Y.)|October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapyRazvan Cristescu, Robin Mogg, Mark Ayers, et al.
Gynecologic Oncology|October 20, 2023
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100Jonathan A Ledermann, Ronnie Shapira-Frommer, Alessandro D Santin, et al.
Nature Communications|November 20, 2014
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencingSwee Seong Wong, Kyoung-Mee Kim, Jason C Ting, et al.
Plos One|October 8, 2014
MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRobert N Booher, Harold Hatch, Brian M Dolinski, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Cancer Research|February 9, 2024
Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung AdenocarcinomaHandan Xiang, Yidan Pan, Marc A Sze, et al.
Nature Medicine|April 21, 2015
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesRazvan Cristescu, Jeeyun Lee, Michael Nebozhyn, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Science (New York, N.Y.)|October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapyRazvan Cristescu, Robin Mogg, Mark Ayers, et al.
Gynecologic Oncology|October 20, 2023
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100Jonathan A Ledermann, Ronnie Shapira-Frommer, Alessandro D Santin, et al.
Nature Communications|November 20, 2014
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencingSwee Seong Wong, Kyoung-Mee Kim, Jason C Ting, et al.
Plos One|October 8, 2014
MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRobert N Booher, Harold Hatch, Brian M Dolinski, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Cancer Research|February 9, 2024
Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung AdenocarcinomaHandan Xiang, Yidan Pan, Marc A Sze, et al.
Nature Medicine|April 21, 2015
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesRazvan Cristescu, Jeeyun Lee, Michael Nebozhyn, et al.
Pageof 4